Mount Sinai pilots detect fetal heart issues using FDA-approved AI, improving congenital defect detection and reducing ultrasound reading time.

Fetal heart monitoring is a common practice used by healthcare providers to examine a baby’s heart rate during the latter ...

Medical devicemaker BrightHeart has earned FDA clearance for its artificial intelligence software designed to transform prenatal ultrasound evaluations of the fetal heart. Congenital heart defects ...

We should embrace innovation and technology that is available to maximize quality patient care, one Mount Sinai doctor said.

Please provide your email address to receive an email when new articles are posted on . An AI software system improved ultrasound detection of fetal congenital heart defects compared with unaided ...

PARIS--(BUSINESS WIRE)--BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announces it has received FDA 510(k) clearance for its first artificial intelligence ...

Doctors in the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai have become the first in New York City to implement an artificial intelligence (AI ...

The Supreme Court is expected to overturn Roe v. Wade, the 1973 decision that guaranteed access to an abortion, according to a leaked draft opinion published by Politico on Monday. The court confirmed ...